Drug Safety Matters
A podcast by Uppsala Monitoring Centre
52 Episodio
-
#35 Veterinary pharmacovigilance part 2 – James Mount
Pubblicato: 28/01/2025 -
#34 Veterinary pharmacovigilance, Part I – James Mount
Pubblicato: 17/12/2024 -
#33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias
Pubblicato: 29/11/2024 -
#32 Pharmacovigilance in older adults – Giovanni Furlan
Pubblicato: 25/10/2024 -
#31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori
Pubblicato: 30/09/2024 -
Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects
Pubblicato: 26/08/2024 -
Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance
Pubblicato: 27/06/2024 -
#30 Preventing and reporting medication errors – Rabat CC & UMC
Pubblicato: 15/05/2024 -
#29 When medicines change our behaviour – Michele Fusaroli
Pubblicato: 23/04/2024 -
#28 Catching black swans – François Montastruc
Pubblicato: 29/02/2024 -
#27 When drugs damage the liver – Rita Baião
Pubblicato: 01/02/2024 -
#26 What's trending in pharmacovigilance? – Angela Caro
Pubblicato: 20/12/2023 -
#25 A week in the name of medicines safety – part 2
Pubblicato: 13/11/2023 -
#24 A week in the name of medicines safety – part 1
Pubblicato: 02/11/2023 -
Uppsala Reports Long Reads – The colour of signals
Pubblicato: 29/09/2023 -
Uppsala Reports Long Reads – Empowering patients as partners
Pubblicato: 05/09/2023 -
#23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić
Pubblicato: 27/06/2023 -
#22 Reforming pharmacovigilance education – Michael Reumerman
Pubblicato: 08/05/2023 -
#21 Unlocking the power of real-world data – Patrick Ryan
Pubblicato: 30/03/2023 -
#20 The evidence for signals – Daniele Sartori
Pubblicato: 23/02/2023
Drug Safety Matters brings you the best stories from the world of pharmacovigilance. Through in-depth interviews with our guests, we cover new research and trends, and explore the most pressing issues in medicines safety today. Produced by Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring.
